Artículos recomendados2

« Previous Entries

Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

Martes, septiembre 15th, 2015

Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Caplin ME, Baudin E, Ferolla P, et al. Ann Oncol. 2015 Aug;26(8):1604-20. Consenso de expertos de la Sociedad Europea de Tumores Neuroendocrinos donde recomiendan las mejores prácticas para el manejo de los tumores neuroendocrinos […]

Pembrolizumab versus Ipilimumab in Advanced Melanoma.

Miércoles, abril 22nd, 2015

Pembrolizumab versus Ipilimumab in Advanced Melanoma. Robert C, Schachter J, Long GV et al N Engl J Med. 2015 Apr 19. [Epub ahead of print] Ensayo clínico aleatorizado fase III entre dos inhibidores del punto de control inmune, en el que se evidencia que el pembrolizumab, comparado con ipilimumab, prolonga la supervivencia libre de progresión […]

Clinical Cancer Advances 2015

Viernes, marzo 6th, 2015

Clinical Cancer Advances 2015: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology Masters GA, Krilov L, Bailey HH, et al. J Clin Oncol. 2015 Mar 1;33(7):786-809. doi: 10.1200/JCO.2014.59.9746. Epub 2015 Jan 20. Hace diez años la Sociedad Americana de Oncología Clínica (ASCO) anunció los principales avances en las investigaciones, en […]

Artículos de Oncología más descargados en Wiley durante el 2014

Jueves, febrero 5th, 2015

La prestigiosa editorial Wiley ha compilado una selección de los cinco artículos más descargados de todas las especialidades durante el año 2014. Ponemos a su disposición de forma gratuita los seleccionados en Oncología: Cancer statistics, 2014 Colorectal cancer statistics, 2014 Obesity and economic environments Breast cancer statistics, 2013 Annual Report to the Nation on the […]

Nivolumab in Previously Untreated Melanoma without BRAF Mutation

Domingo, febrero 1st, 2015

Nivolumab in Previously Untreated Melanoma without BRAF Mutation Robert C, Long GV, Brady B, et al N Engl J Med. 2015 Jan 22;372(4):320-30. doi: 10.1056/NEJMoa1412082. Epub 2014 Nov 16. Ensayo clínico fase 3 en el cual aleatorizaron 418 pacientes con diagnóstico de Melanoma metastásico, sin tratamiento previo, y sin mutación del BRAF, a recibir el […]

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO).

Viernes, abril 25th, 2014

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO). Popescu RA, Schäfer R, Califano R, et al. Ann Oncol. 2014 Jan;25(1):9-15. doi: 10.1093/annonc/mdt522. Epub 2013 Dec 13. El número de pacientes con cáncer aumenta cada día y […]

The mutational spectrum of squamous-cell carcinoma of the head and neck: Targetable genetic events and clinical impact.

Viernes, abril 25th, 2014

The mutational spectrum of squamous-cell carcinoma of the head and neck: Targetable genetic events and clinical impact. Mountzios G, Rampias T, Psyrri A. Ann Oncol. 2014 Apr 8. [Epub ahead of print] El cáncer de células escamosas de cabeza y cuello (CCECC) representa una enfermedad heterogénea, con varios factores etiológicos implicados en la génesis de […]

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.

Domingo, febrero 2nd, 2014

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial. Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, et al; on behalf of the IBIS-II investigators. Lancet. 2013 Dec 12. pii: S0140-6736(13)62292-8. doi: 10.1016/S0140-6736(13)62292-8. [Epub ahead of print] Los inhibidores de la aromatasa previenen […]

Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH

Domingo, febrero 2nd, 2014

Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH Carrier M, Khorana AA, Zwicker JI, Noble S, Lee AY; subcommittee on Haemostasis and Malignancy for the SSC of the ISTH. J Thromb Haemost. 2014 Jan;12(1):116-7. doi: 10.1111/jth.12444. El presente artículo nos orienta sobre […]

Clinical cancer advances 2013: annual report on progress against cancer from the american society of clinical oncology

Sábado, enero 18th, 2014

Clinical cancer advances 2013: annual report on progress against cancer from the american society of clinical oncology. Patel JD, Krilov L, Adams S, et al. J Clin Oncol. 2014 Jan 10;32(2):129-60. doi: 10.1200/JCO.2013.53.7076. Epub 2013 Dec 10. Los estudios presentados en “Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer de la Sociedad Americana […]

« Previous Entries